RxDoctor Payments Data

Syed Aziz

Internal Medicine · McKinney, TXNPI 1386634293

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $944 and has fallen 96.0% since, to $37 in 2023.

$2,071in general payments, 2019–2025

Across 121 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$309
  • Novo Nordisk$296
  • AstraZeneca$259
  • Sanofi-aventis U.S. LLC$250
  • Pfizer$164
  • Amarin Pharma, Inc.$127
  • plus $666 from 15 others

What the payments were for

  • Food & beverage$2,071100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,071 in reported general payments places this provider in the 80th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in McKinney

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →